Increasing prevalence of pulmonary embolism is driving growth of Urokinase market
Urokinase is a type of thrombolytic drug used to dissolves unwanted blood clots in the lungs.
Jiangsu Aidea Pharmaceutical Co Ltd, Jiangxi Haoran Bio-Pharma Co., Ltd, Cadila Healthcare Limited, TAJ Pharmaceuticals Limited, Microbix Biosystems Inc, Syner Medica LTD, ImaRx Therapeutics, Inc, and Wilex AG.
Key Market Drivers:
High prevalence of pulmonary embolism is a key factor fostering urokinase market growth. According to National Library of Health in 2018, pulmonary embolism have high prevalence globally with 10 million cases per year.
𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/4151
Increasing usage of urokinase drug for heart related disease treatment is again augmenting growth of the market. For example, in June 2020, Hospital of Zhenghou University started clinical trial on the treatment of minor heart stroke with urokinase thrombolysis, which is expected to complete in 2021.
Covid-19 Impact Analysis
During Covid-19 pandemic the market of urokinase drug witness strong growth due to increasing cases of pulmonary embolism in patients suffering from Covid-19 infection. According to American society of Hematology July 2020, 15-20% of patients suffering from acute pulmonary embolism and deep vein thrombosis require mechanical ventilation and blood clot busting agents after getting infected by COVID-19 infection. Additionally, According to World Health Organization 2019, it is observed that COVID-19 infection leads to formation of blood clots in patients, thus there is need of blood clot busting agents, when mechanical ventilators are in shortage due to increase in patient population infected by COVID-19 infection.
𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐨𝐫 𝐐𝐮𝐞𝐫𝐲 𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐛𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠, 𝐕𝐢𝐬𝐢𝐭 𝐚𝐭 – https://www.coherentmarketinsights.com/insight/talk-to-analyst/4151
- The urokinase market is expected to exhibit a CAGR of 7.1% over the forecast period owing to the advancement in the treatment process.
- North America is expected to gain significant growth over the forecast period owing to the increasing prevalence of pulmonary embolism in the region. According to the Centers for Disease Control and Prevention, 60,000-100,000 Americans die of DVT/PE (also called venous thromboembolism). 10 to 30% of people will die within one month of diagnosis. Sudden death is the first symptom in about one-quarter (25%) of people who have a PE.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/4151
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Urokinase Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Urokinase Industry Impact
Chapter 2 Global Urokinase Competition by Types, Applications, and Top Regions and Countries
2.1 Global Urokinase (Volume and Value) by Type
2.3 Global Urokinase (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Urokinase Sales, Consumption, Export, Import by Regions
Chapter 5 North America Urokinase Market Analysis
Chapter 6 East Asia Urokinase Market Analysis
Chapter 7 Europe Urokinase Market Analysis
Chapter 8 South Asia Urokinase Market Analysis
Chapter 9 Southeast Asia Urokinase Market Analysis
Chapter 10 Middle East Urokinase Market Analysis
Chapter 11 Africa Urokinase Market Analysis
Chapter 12 Oceania Urokinase Market Analysis
Chapter 13 South America Urokinase Market Analysis
Chapter 14 Company Profiles and Key Figures in Urokinase Business
Chapter 15 Global Urokinase Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027